Xeris Biopharma (NASDAQ: XERS) is a commercial stage biopharmaceutical company, commercializing therapeutics in Endocrinology, Neurology and Rare Diseases, and leveraging proprietary non-aqueous formulation platforms to develop novel ultra highly concentrated (>450mg/mL), ready-to-use, subcutaneously injectable biologics and small molecule drugs
Address
ChicagoIllinois
United States
